Clinical Advances in Allergy Management

Up to 60 million people in the United States are affected by allergic diseases. Not only do these conditions affect overall patient health and quality of life, they also carry significant economic burden. Clinical Advances in Allergy Management is a unique collection of educational activities delivered by leading experts in the field designed to address the challenges of allergy management: selecting the most effective treatment approach, improving patient adherence to treatment, and utilizing the latest available therapies. This collection will be relevant to your practice.

Diagnosis to Treatment Optimization: A Case-Based Approach to Effective Management of Allergic Disease CME
How would you handle these cases of allergic rhinitis and asthma?
Sept 18, 2014
Clinical Developments in Allergen Immunotherapy CME
Is it time to revisit the role of immunotherapy in your practice?
July 23, 2014

Steering Committee Chair

Linda S. Cox, MD
Associate Clinical Professor,
Department of Medicine,
Nova Southeastern University,
Davie, Florida

Steering Committee Members

Tolly E. G. Epstein, MD, MS
Assistant Professor
of Clinical Medicine,
University of Cincinnati,
Cincinnati, Ohio
Mark S. Dykewicz, MD
Raymond and Alberta Slavin
Endowed Chair in Allergy
& Immunology;
Professor of Internal Medicine;
Chief, Allergy & Immunology,
Saint Louis University
School of Medicine,
St. Louis, Missouri

Peter S. Creticos, MD
Associate Professor of Medicine,
Department of Medicine,
Johns Hopkins University
School of Medicine;
Johns Hopkins Asthma
& Allergy Center,
Baltimore, Maryland;
Director, of Clinical Research,
Creticos Research Group, LLC,
Crownsville, Maryland

Supported by an independent educational
grant from

Merck & Co., Inc.

Downloadable Slide Kit

The Evolving Role of Immunotherapy in the Management of Allergic Diseases
This downloadable resource is available to assist clinicians in selecting the most effective immunotherapy treatment options for the management of their patients with allergic diseases.

Clinical Articles

Steering Committee

Linda S. Cox, MD

Linda S. Cox, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Stallergenes

Tolly E. G. Epstein, MD, MS

Tolly E. G. Epstein, MD, MS, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Teva Pharmaceuticals, Inc.

Mark S. Dykewicz, MD

Mark S. Dykewicz, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consult for: Merck & Co., Inc.
Received grants for clinical research from: Novartis Pharmaceuticals Corporation

Peter S. Creticos, MD

Peter S. Creticos, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consult for: Circassia, Ltd.; Greer
Received grants for clinical research from: Circassia, Ltd.; Greer; Merck & Co., Inc.

	Which of the following allergic diseases are you most interested in learning more about?
		Asthma
		Allergic rhinoconjunctivitis
		Stinging insect allergy
		Food allergy
		Atopic dermatitis